Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  134 results for ""Antimetabolites""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Editorial & Opinion

Fingerprint loss associated with topical 5-fluorouracil cream.

  • Authors : Chow WTH; Blenheim Head and Neck Unit, Churchill Hospital, Oxford University NHS Foundation Trust, Oxford, UK.; Potter M

Subjects: Antimetabolites, Antineoplastic*/Antimetabolites, Antineoplastic*/Antimetabolites, Antineoplastic*/adverse effects ; Fluorouracil*/Fluorouracil*/Fluorouracil*/adverse effects; Administration, Topical

  • Source: Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Jul; Vol. 47 (7), pp. 1371-1372. Date of Electronic Publication: 2022 Apr 21.Publisher: Oxford University Press Country of Publication: England NLM ID: 7606847 Publication Model: Print-Electronic Cited

Record details

×
Electronic Resource

Loss of atm sensitises p53-deficient cells to topoisomerase poisons and antimetabolites

Subjects: 142-005; 610 Medicine & health; Journal Article

  • Source: Fedier, A (2003). Loss of atm sensitises p53-deficient cells to topoisomerase poisons and antimetabolites. Annals of Oncology, 14(6):938-945.

Record details

×
Report

A dog's life: an unfamiliar and lethal side effect of topical 5-fluorouracil.

  • Authors : Khoo AA; Department of Plastic Surgery, Norfolk and Norwich University Hospital, Norwich, Norfolk, NR4 7UY, UK.; Mulgrew S

Subjects: Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*adverse effects ; Fluorouracil/Fluorouracil/Fluorouracil/*adverse effects ; Iatrogenic Disease/Iatrogenic Disease/Iatrogenic Disease/*veterinary

  • Source: Clinical and experimental dermatology [Clin Exp Dermatol] 2018 Aug; Vol. 43 (6), pp. 732. Date of Electronic Publication: 2018 Jun 11.Publisher: Oxford University Press Country of Publication: England NLM ID: 7606847 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Evidence of a clinically significant interaction between warfarin and intravesical gemcitabine.

  • Authors : Kurtzhalts K; Veterans Affairs Western New York Healthcare System, Buffalo, NY. .; Gee ME

Subjects: Anticoagulants/Anticoagulants/Anticoagulants/*therapeutic use ; Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*therapeutic use ; Carcinoma, Transitional Cell/Carcinoma, Transitional Cell/Carcinoma, Transitional Cell/*drug therapy

  • Source: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2016 Oct 01; Vol. 73 (19), pp. 1508-11.Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print Cited Medium:

Record details

×
Editorial & Opinion

Keeping sterile 0.9% sodium chloride, 5% dextrose, and lactated Ringer's solutions for injection cold enough for dilution of decitabine in isolators.

  • Authors : Correard F; Oncopharma UnitPharmacy DepartmentLa Timone University Teaching HospitalAssistance Publique-Hôpitaux de MarseilleMarseille, France.; Savry A

Subjects: Cold Temperature*; Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*chemistry ; Azacitidine/Azacitidine/Azacitidine/*analogs & derivatives

  • Source: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2016 Jun 01; Vol. 73 (11), pp. 748-50.Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial.

  • Authors : Israeli E; Gastroenterology and Liver Units, Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem.; Goldin E

Subjects: Antimetabolites/Antimetabolites/Antimetabolites/*administration & dosage ; Crohn Disease/Crohn Disease/Crohn Disease/*drug therapy ; Delayed-Action Preparations/Delayed-Action Preparations/Delayed-Action Preparations/*administration & dosage

  • Source: Clinical and experimental immunology [Clin Exp Immunol] 2015 Aug; Vol. 181 (2), pp. 362-72.Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Addressing barriers to increased adoption of DPYD genotyping at a large multisite cancer center.

  • Authors : Morris SA; Department of Cancer Pharmacology & Pharmacogenomics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.; Moore DC

Subjects: Dihydrouracil Dehydrogenase (NADP)*/Dihydrouracil Dehydrogenase (NADP)*/Dihydrouracil Dehydrogenase (NADP)*/genetics ; Dihydrouracil Dehydrogenase (NADP)*/Dihydrouracil Dehydrogenase (NADP)*/Dihydrouracil Dehydrogenase (NADP)*/metabolism ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy

  • Source: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2023 Sep 22; Vol. 80 (19), pp. Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Resumption of high-dose methotrexate after methotrexate-induced nephrotoxicity and carboxypeptidase G2 use.

  • Authors : Snyder RL; Pediatric Oncology/Bone Marrow Transplantation Service, Pharmacy Department, Children's Hospital of Orange County, CA 92868, USA.

Subjects: Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*administration & dosage ; Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*adverse effects ; Methotrexate/Methotrexate/Methotrexate/*administration & dosage

  • Source: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2007 Jun 01; Vol. 64 (11), pp. 1163-9.Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Agrocybe aegerita polysaccharide combined with chemotherapy improves tumor necrosis factor-α and interferon-γ levels in rat esophageal carcinoma.

  • Authors : Ji Y; Department of Cardiothoracic Surgery, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, Jiangsu Province, China.; Zheng MF

Subjects: Agrocybe*; Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*pharmacology ; Body Weight/Body Weight/Body Weight/*drug effects

  • Source: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus [Dis Esophagus] 2013 Nov-Dec; Vol. 26 (8), pp. 859-63. Date of Electronic Publisher: Oxford University Press Country of Publication: United States NLM ID: 8809160 Publication Model: Print-Electronic

Record details

×
Academic Journal

Azacitidine: a novel agent for myelodysplastic syndromes.

Subjects: Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*pharmacology ; Azacitidine/Azacitidine/Azacitidine/*pharmacology ; Myelodysplastic Syndromes/Myelodysplastic Syndromes/Myelodysplastic Syndromes/*drug therapy

  • Source: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2005 Aug 01; Vol. 62 (15), pp. 1567-73.Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print Cited Medium:

Record details

×
  • 1-10 of  134 results for ""Antimetabolites""